Physician-scientist @CarlDeSelm presented his research findings at #AACR26!
"A novel, first in class chimeric antigen receptor dendritic cell platform driving broad and durable antitumor immunity in solid tumors"
#immunotherapy #CancerResearch https://t.co/hk8UZmorsS